Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0005121
UniProt IDP29083
Primary gene name(s)GTF2E1
Synonym gene name(s)TF2E1
Protein nameGeneral transcription factor IIE subunit 1
Protein functionRecruits TFIIH to the initiation complex and stimulates the RNA polymerase II C-terminal domain kinase and DNA-dependent ATPase activities of TFIIH. Both TFIIH and TFIIE are required for promoter clearance by RNA polymerase.
Subcellular locationNucleus.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P29083
Gene Ontology
(Biological Process)
Complete annatation
regulation of transcription, DNA-templated [GO:0006355];
snRNA transcription from RNA polymerase II promoter [GO:0042795];
transcription elongation from RNA polymerase II promoter [GO:0006368];
transcription from RNA polymerase II promoter [GO:0006366];
transcription initiation from RNA polymerase II promoter [GO:0006367];
viral process [GO:0016032]
Gene Ontology
(Molecular Function)
Complete annatation
metal ion binding [GO:0046872];
sequence-specific DNA binding [GO:0043565]
Gene Ontology
(Cellular Component)
Complete annatation
cytoplasm [GO:0005737];
nucleoplasm [GO:0005654];
nucleus [GO:0005634]
Protein-protein interaction109215
Phylogenetic treeP29083
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
      unknown
Brass et al., Science, 2008
      unknown
Smith et al., J. Immunol, 2010
      unknown
Interferon-stimulated
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model


DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD30.5952453846926980.07090540725892210.132673655891555
AZA vs. DISU-0.1419922600791410.5779698185503750.954676050574994
AZA vs. IL70.0498570512266010.7986458785162210.999311006273513
AZA vs. SAHA0.09205121288963290.7086654851268760.918128364658576
DISU vs. CD3-0.7498555833938190.03998493647164470.0901754835986792
DISU vs. IL70.1834121130644520.4703593597438310.808020432918392
DISU vs. SAHA0.2346880813885940.4235623701466350.775918759105463
DMSO vs. AZA-0.1367458749678280.4255402811395141
DMSO vs. CD3-0.7443433540941350.02094900708228430.0465935694957646
DMSO vs. DISU0.00316014618519110.9897605729993430.99806609310612
DMSO vs. IL70.193916884349880.2895349956904360.776644138795965
DMSO vs. SAHA0.22141974488450.3527912076161260.702546877400509
HIV vs. Mock in Activation0.006510798773937510.9916624580250770.999983755607037
HIV vs. Mock in Latency-0.0304299655744780.856624062037680.999834320637052
IL7 vs. CD3-0.5360447168999240.09698068957193270.18534169315554
SAHA vs. CD3-0.5286398733045010.136708087757610.223617809888981
SAHA vs. IL70.03769071969051980.8781872311783180.951537832287375
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) unknown
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK -0.02196 0.916165
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
1.043 1.045 1.034 0.924 0.993
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
1VD4 NMR - A=113-174.
2JTX NMR - A=336-439.
2RNQ NMR - A=378-439.
2RNR NMR - A=378-439.
5IY6 EM 7.2Å Q=1-439.
5IY7 EM 8.6Å Q=1-439.
5IY8 EM 7.9Å Q=1-439.
5IY9 EM 6.3Å Q=1-439.
5IYA EM 5.4Å Q=1-439.
5IYB EM 3.9Å Q=1-439.
5IYC EM 3.9Å Q=1-439.
5IYD EM 3.9Å Q=1-439.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

HIV Partner Interaction Type PubMed
HIV-1 virus replication enhanced by expression of human gene 22404213
Tat interacts with 8849451
8934526
9054383
9121429
21489275

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa03022 Basal transcription factors - Homo sapiens (human)
hsa05169 Epstein-Barr virus infection - Homo sapiens (human)
hsa05203 Viral carcinogenesis - Homo sapiens (human)
Menu